As of 09-Oct-2026
4QFY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 3.2B
12MFY26: Rs 14.0B (+6.5%)
Net profit
Rs (101M)
12MFY26: Rs 782M (-12.3%)
EPS
Rs (0.44)
12MFY26: Rs 3.43 (-12.1%)
DPS
Rs 0.00
12MFY26: Rs 0.00 (-100.0%)
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
114.23M (50.00%)
Free Float shares
114.23M (50.00%)
Market Cap
14.80B
#8 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to CPHL by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| SEARL The Searle Company | 77.86 | Rs 45.6B | 104.4x | - |
| AGP AGP | 155.48 | Rs 43.8B | 11.9x | 5.1% |
| HPL Hoechst Pakistan | 3,961.82 | Rs 38.1B | 10.1x | 6.8% |
| CPHL Citi Pharma (this stock) | 64.76 | Rs 14.6B | 19.1x | 5.5% |
| FEROZ Ferozsons Laboratories | 328.26 | Rs 14.6B | 15.1x | 1.2% |
| MACTER Macter International | 249.15 | Rs 11.4B | 16.3x | 0.8% |
| BFBIO BF Biosciences | 124.18 | Rs 10.9B | 17.3x | - |
Citi Pharma Limited was incorporated as a private limited company in Pakistan under the Repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The company was converted into public unlisted company with effect from October 13, 2020. The Company was listed on Pakistan Stock Exchange on July 09, 2021. Citi Pharma Ltd. (CPHL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 and KMI-30 indices. It is marked Shariah-compliant on the KMI screening.
Citi Pharma Limited was incorporated as a private limited company in Pakistan under the Repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The company was converted into public unlisted company with effect from October 13, 2020. The Company was listed on Pakistan Stock Exchange on July 09, 2021.
Citi Pharma Ltd. (CPHL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 and KMI-30 indices. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare CPHL with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
